As of 2025-05-25, the Gross Margin of HPGC Renmintongtai Pharmaceutical Corp (600829.SS) is 8.6%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 8.6% |
2023-12-31 | 9.6% |
2022-12-31 | 9.5% |
2021-12-31 | 10.7% |
2020-12-31 | 11.5% |
2019-12-31 | 12.2% |
2018-12-31 | 12.8% |
2017-12-31 | 11.6% |
2016-12-31 | 10% |
2015-12-31 | 11.1% |